Treace Medical Concepts (TMCI) Asset Utilization Ratio (2021 - 2026)
Treace Medical Concepts (TMCI) posted Asset Utilization Ratio of 1.11 for Q1 2026, up 0.72% on a QoQ basis from 1.1 in Q4 2025, and up 11.0% year-over-year from 1.0 in Q1 2025.
Treace Medical Concepts (TMCI) Asset Utilization Ratio (2021 - 2026) Analysis & Trends
Treace Medical Concepts' Asset Utilization Ratio history runs 6 years deep, the most recent figure standing at 1.11 for Q1 2026.
- Quarterly Asset Utilization Ratio rose 11.0% year-over-year to 1.11 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.11 (up 11.0% YoY) and the FY2025 annual result came in at 1.04, up 16.87% from the prior year.
- Asset Utilization Ratio was 1.11 for Q1 2026 at Treace Medical Concepts, up from 1.1 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 1.11 in Q1 2026 and bottomed at 0.67 in Q2 2023.
- A 5-year average of 0.88 and a median of 0.85 in 2024 frame the typical range for Asset Utilization Ratio.
- Peak annual rise in Asset Utilization Ratio reached 32.58% in 2022, while the deepest fall reached 55.46% in 2022.
- Treace Medical Concepts' Asset Utilization Ratio stood at 0.9 in 2022, then decreased by 15.46% to 0.76 in 2023, then increased by 28.08% to 0.97 in 2024, then grew by 12.83% to 1.1 in 2025, then advanced by 0.72% to 1.11 in 2026.
- Business Quant data shows TMCI's Asset Utilization Ratio at 1.11 in Q1 2026, 1.1 in Q4 2025, and 1.09 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.46 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 0.54 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.39 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 0.47 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 0.47 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 0.74 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.65 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.57 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Treace Medical Concepts | 261.60 Mn | 209.75 Mn | 37.41 Mn | 1.11 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.11 |
| Dec 31, 2025 | 1.10 |
| Sep 30, 2025 | 1.09 |
| Jun 30, 2025 | 1.04 |
| Mar 31, 2025 | 1.00 |
| Dec 31, 2024 | 0.97 |
| Sep 30, 2024 | 0.92 |
| Jun 30, 2024 | 0.85 |
| Mar 31, 2024 | 0.79 |
| Dec 31, 2023 | 0.76 |
| Sep 30, 2023 | 0.71 |
| Jun 30, 2023 | 0.67 |
| Mar 31, 2023 | 0.76 |
| Dec 31, 2022 | 0.90 |
| Sep 30, 2022 | 0.80 |
| Jun 30, 2022 | 0.75 |
| Mar 31, 2022 | 0.73 |
| Dec 31, 2021 | 0.68 |
| Sep 30, 2021 | 0.61 |
| Jun 30, 2021 | 0.87 |